The pharmacological activation of S1R prolongs the survival of SOD1 ALS mice [50–52], and S1R inactivation or loss determines MN degeneration [53], suggesting SR1 as a promising target for further preclinical ALS research. The gene discussed is TMBIM4; the disease is amyotrophic lateral sclerosis.